Home » Newsletters » BioWorld Science

BioWorld Science

July 1, 2013

View Archived Issues

The identification of biomarkers to predict the predisposition to depression following child birth

The first ligand-inducible fluorophore for the detection of a specific human clinical biomarker

Novel drug candidate for L-Dopa-induced dyskinesia

IL12RB1 is identified as a novel candidate gene underlying ALPS type III

Dompe and SatRx set to develop drug against liver transplant rejection

VX-509 modulates markers of rheumatoid arthritis disease activity

GE Healthcare presents new radiotracers for brain imaging

Iron in gut lavage fluid is increased in patients with colon cancer

VivaMab and ADC Therapeutics enter licensing agreement for ADC candidate

Amicus to develop chaperone-advanced replacement therapy for MPS I

Preclinical investigations of the safety and efficacy of drugs for the treatment of tinnitus

MediciNova to conduct preclinical studies of MN-001 for NASH

Phase I atopic dermatitis study initiated in Japan

Sucampo receives milestone payment for Amitiza launch

MorphoSys and Celgene create alliance to develop MOR-202 for multiple myeloma

Pergamum reports follow-up data from phase II PXL-01 study

Forest Laboratories reports phase III data for nebivolol and valsartan

European marketing authorization for Brinavess transferred to Cardiome

Imperial Innovations presents new agents for protozoal infections

Novel kappa receptor antagonists disclosed by Research Triangle Institute

Chiesi Farmaceutici divulges new protein kinase p38 inhibitors

First approval achieved for gout and hyperuricemia therapeutic in Japan

Novel BACE1 inhibitors patented by Janssen Pharmaceutica

Subcutaneous Orencia approved in Japan

Bonviva approved in Japan for osteoporosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...